niacinamide has been researched along with Chronic Primary Open Angle Glaucoma in 6 studies
nicotinamide : A pyridinecarboxamide that is pyridine in which the hydrogen at position 3 is replaced by a carboxamide group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Of these, 42 patients with treated open-angle glaucoma and moderate visual field loss in at least 1 eye were selected for inclusion and randomized." | 1.72 | Nicotinamide and Pyruvate for Neuroenhancement in Open-Angle Glaucoma: A Phase 2 Randomized Clinical Trial. ( Blumberg, DM; Cioffi, GA; De Moraes, CG; John, SWM; Liebmann, JM; Williams, PA, 2022) |
| " The quantitative dosage also disclosed a significantly lower plasma nicotinamide concentration (-33%; P = 0." | 1.51 | Nicotinamide Deficiency in Primary Open-Angle Glaucoma. ( Allouche, S; Amati-Bonneau, P; Bocca, C; Bonneau, D; Chao de la Barca, JM; Coulbault, L; Gohier, P; Guehlouz, K; Kouassi Nzoughet, J; Lenaers, G; Leruez, S; Milea, D; Muller, J; Procaccio, V; Reynier, P; Simard, G, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 5 (83.33) | 2.80 |
| Authors | Studies |
|---|---|
| De Moraes, CG | 2 |
| John, SWM | 1 |
| Williams, PA | 2 |
| Blumberg, DM | 1 |
| Cioffi, GA | 1 |
| Liebmann, JM | 2 |
| Leung, CKS | 1 |
| Ren, ST | 1 |
| Chan, PPM | 1 |
| Wan, KHN | 1 |
| Kam, AKW | 1 |
| Lai, GWK | 1 |
| Chiu, VSM | 1 |
| Ko, MWL | 1 |
| Yiu, CKF | 1 |
| Yu, MCY | 1 |
| Quah Qin Xian, N | 1 |
| Wong, FYK | 1 |
| Hui, F | 1 |
| Tang, J | 1 |
| McGuinness, MB | 1 |
| Hadoux, X | 1 |
| Casson, RJ | 1 |
| Coote, M | 1 |
| Trounce, IA | 1 |
| Martin, KR | 1 |
| van Wijngaarden, P | 1 |
| Crowston, JG | 1 |
| Kouassi Nzoughet, J | 1 |
| Chao de la Barca, JM | 1 |
| Guehlouz, K | 1 |
| Leruez, S | 1 |
| Coulbault, L | 1 |
| Allouche, S | 1 |
| Bocca, C | 1 |
| Muller, J | 1 |
| Amati-Bonneau, P | 1 |
| Gohier, P | 1 |
| Bonneau, D | 1 |
| Simard, G | 1 |
| Milea, D | 1 |
| Lenaers, G | 1 |
| Procaccio, V | 1 |
| Reynier, P | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Nicotinamide and Pyruvate for Open Angle Glaucoma: A Randomized Clinical Study[NCT05695027] | Phase 2/Phase 3 | 188 participants (Anticipated) | Interventional | 2023-03-14 | Recruiting | ||
| Nutritional Supplements and Performance During Visual Field Testing[NCT03797469] | 32 participants (Actual) | Interventional | 2019-04-15 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 trials available for niacinamide and Chronic Primary Open Angle Glaucoma
| Article | Year |
|---|---|
Nicotinamide riboside as a neuroprotective therapy for glaucoma: study protocol for a randomized, double-blind, placebo-control trial.
Topics: Glaucoma; Glaucoma, Open-Angle; Humans; Multicenter Studies as Topic; Nerve Fibers; Neuroprotection; | 2022 |
Improvement in inner retinal function in glaucoma with nicotinamide (vitamin B3) supplementation: A crossover randomized clinical trial.
Topics: Dietary Supplements; Electroretinography; Glaucoma; Glaucoma, Open-Angle; Humans; Niacinamide; Photi | 2020 |
4 other studies available for niacinamide and Chronic Primary Open Angle Glaucoma
| Article | Year |
|---|---|
Nicotinamide and Pyruvate for Neuroenhancement in Open-Angle Glaucoma: A Phase 2 Randomized Clinical Trial.
Topics: Animals; Double-Blind Method; Female; Glaucoma; Glaucoma, Open-Angle; Humans; Intraocular Pressure; | 2022 |
Nicotinamide and Pyruvate for Neuroenhancement in Open-Angle Glaucoma: A Phase 2 Randomized Clinical Trial.
Topics: Animals; Double-Blind Method; Female; Glaucoma; Glaucoma, Open-Angle; Humans; Intraocular Pressure; | 2022 |
Nicotinamide and Pyruvate for Neuroenhancement in Open-Angle Glaucoma: A Phase 2 Randomized Clinical Trial.
Topics: Animals; Double-Blind Method; Female; Glaucoma; Glaucoma, Open-Angle; Humans; Intraocular Pressure; | 2022 |
Nicotinamide and Pyruvate for Neuroenhancement in Open-Angle Glaucoma: A Phase 2 Randomized Clinical Trial.
Topics: Animals; Double-Blind Method; Female; Glaucoma; Glaucoma, Open-Angle; Humans; Intraocular Pressure; | 2022 |
Combined Use of Nicotinamide and Pyruvate for Neuroenhancement in Open-Angle Glaucoma-Reply.
Topics: Glaucoma; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Niacinamide; Pyruvic Acid | 2022 |
Combined Use of Nicotinamide and Pyruvate for Neuroenhancement in Open-Angle Glaucoma.
Topics: Glaucoma; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Niacinamide; Pyruvic Acid | 2022 |
Nicotinamide Deficiency in Primary Open-Angle Glaucoma.
Topics: Adult; Aged; Aged, 80 and over; Case-Control Studies; Chromatography, Liquid; Cohort Studies; Female | 2019 |